Triamcinolone is a corticosteroid used to treat various inflammatory conditions in the body from allergic rhinitis to acute exacerbations of multiple sclerosis. Triamcinolone can be used as a one time adjunct treatment of osteoarthritic knee pain, or first line as a topical treatment of corticosteroid responsive dermatoses. Triamcinolone is more commonly seen in the forms triamcinolone hexacetonide, triamcinolone acetonide, and triamcinolone diacetate.
Triamcinolone was granted FDA approval on 3 December 1957. In October 2021, a suspension of triamcinolone acetonide was approved for suprachoroidal injection - the first suprachoroidal injection to receive FDA approval - for the treatment of patients with macular edema associated with uveitis.
肾上腺皮质激素类药。主要用于过敏性与自身免疫性炎症性疾病。由于本品潴钠作用较弱,故一般不用作肾上腺皮质功能减退的替代治疗。
Wuhan General Hospital of PLA, Wuhan, Hubei, China
The Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
Shenzhen Aier Eye Hospital, Shenzhen, Guangdong, China
Northwestern University, Feingberg School of Medicine, Chicago, Illinois, United States
Sir Run Run Shaw Hospital, Medical College of Zhejiang University, Hang Zhou, Zhejiang, China
Northwestern Medicine Department of Orthopaedic Surgery, Chicago, Illinois, United States
CHU Angers, Angers, France
CHU de Brest, Brest, France
CHU de Nantes, Nantes, France
Duke Eye Center, Durham, North Carolina, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.